Labshake search
Citations for BioLegend :
1 - 50 of 7204 citations for 7 Fluoro 6 amino 2H 1 4 benzoxazin 3 4H one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2024Quote: ... Each patient was also stained with one of TotalSeq™-C0251/2/3/4 Antibody (Biolegend, Cat: 394661/3/5/7, 1:100) for sample multiplexing ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... 7-amino-actinomycin D viability staining solution (7-AAD; BioLegend) was added to each well at a final concentration of 600 ng/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... and then incubated overnight at 4 °C with primary antibodies directed against amino acids 6-18 (Tau 12, 1:1,000 dilution, ref: 806501, Biolegend), 159–163 (Tau HT7 ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 20 μg/mL 7-AAD solution (7-amino-actinomycin D, Biolegend, 650 nm) for 15 min at room temperature in dark ...
-
bioRxiv - Cancer Biology 2023Quote: ... Apoptotic B16.F10 cells were stained with 7-Amino-actinomycin D (7-AAD, Biolegend) to determine viability ...
-
bioRxiv - Molecular Biology 2020Quote: ... cell-impermeant dye 7-amino-actinomycin D (7AAD, BioLegend), cells grown in 6-wells plates were collected upon trypsinization ...
-
bioRxiv - Immunology 2023Quote: ... The 7-amino-actinomycin D Viability Staining Solution (BioLegend) was added to eliminate dead cells ...
-
bioRxiv - Immunology 2023Quote: ... a 7-amino actinomycin D viability staining solution (BioLegend) was added to each sample to stain dead cells ...
-
bioRxiv - Biochemistry 2022Quote: ... and 15 μg/mL of 7-amino-actinomycin D (7-AAD) (BioLegend, San Diego, CA, USA) for 2 h at 4 °C ...
-
bioRxiv - Neuroscience 2022Quote: ... 4’,6-diamidino-2-phenylindole (1:10,000; Biolegend) was used.
-
bioRxiv - Cancer Biology 2020Quote: ... Cells were stained with 7-Amino Actinomycin D viability staining solution (7-AAD, BioLegend, San Diego, CA). The suspensions were incubated for 45 min on ice in the dark ...
-
bioRxiv - Cancer Biology 2022Quote: ... and V5-tag (7/4, Biolegend).
-
bioRxiv - Immunology 2023Quote: ... The nuclei were stained with 3 µM DAPI (4’,6-diamidino-2-phenylindole; BioLegend, #422801) for 5 min ...
-
bioRxiv - Immunology 2021Quote: ... All staining were performed in FACS buffer and dead cells were counterstained with 7-amino-actinomycin D (7-AAD, Biolegend). Before analysis ...
-
bioRxiv - Neuroscience 2023Quote: ... Four μg of Tau12 (N-terminal [epitope = amino acids 6-18], BioLegend), HT7 (mid-region [epitope = amino acids 159-163] ...
-
bioRxiv - Physiology 2022Quote: ... Samples were stained with 3 μM of (4’,6-Diamidino-2-Phenylindole, Dilactate (DAPI, Biolegend Cat# 422801)) ...
-
bioRxiv - Genetics 2020Quote: ... 7-aminoactinomycin D (7-AAD) (1:100; Biolegend, 420404) was added as a viability stain ...
-
bioRxiv - Bioengineering 2023Quote: ... 4′,6-diamidino-2-phenylindole (DAPI; BioLegend) was diluted 1:10,000 from a 5 mg mL-1 stock solution in deionized water ...
-
bioRxiv - Microbiology 2024Quote: ... Staining was done with 3-amino-9-ethylcarbazole (AEC) (BioLegend, Amsterdam, The Netherlands) as HRP substrate ...
-
bioRxiv - Immunology 2020Quote: ... 7-AAD (#420404, 1:100, BioLegend), Annexin V (#640947 ...
-
bioRxiv - Immunology 2019Quote: ... or DAPI (4’,6-Diamidino-2-Phenylindole, Dilactate; Biolegend). Intracellular staining was carried out using Human FoxP3 Buffer (BD Biosciences ...
-
bioRxiv - Cell Biology 2019Quote: ... 3 and 6 were stained with Calcein-AM (BIOLEGEND, 425201) and PI (SIGMA ...
-
bioRxiv - Microbiology 2021Quote: ... Cells were then filtered using a 40 μm cell strainer and stained with the Live/Dead dye 7 Amino-actinomycin D (7AAD, Biolegend) and antibodies against CD45.2 (Biolegend ...
-
bioRxiv - Cancer Biology 2023Quote: Cells were stimulated with IFNγ for 4h and the trypizinized cells were immunostained with VCAM1 antibody (1:100 dilution, BV421; BioLegend #305815). eBioscience™ Fixable Viability Dye eFluor™ 780 was used for discriminating dead cells ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD51-PE (1:50, RMV-7, Biolegend), Sca1-PacificBlue (1:100 ...
-
bioRxiv - Immunology 2022Quote: ... for 2h and with Brefeldin A (5ug/ml, Biolegend) added for the last 2h of stimulation prior surface staining ...
-
bioRxiv - Immunology 2023Quote: ... and anti-mouse TotalSeq-A Hashtag antibody (4-6; BioLegend). The enriched samples were then stained with APC-labeled Streptavidin (BioLegend ...
-
bioRxiv - Immunology 2023Quote: ... Sections were stained using a three-colour protocol with 1:100 of each of the following antibodies in IF blocking buffer at 4 °C O/N: Alexa Fluor 488® anti-mouse GL-7 (GL-7; Biolegend, #144612), PE anti-mouse CD3 (145-2C11 ...
-
bioRxiv - Neuroscience 2022Quote: ... Membranes were blocked in TBS-T/5% BSA for one hour at RT and incubated overnight at 4 °C with anti-P62 (SQSTM1) (1:500, #814802, BioLegend), anti-CD107b (LAMP-2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and then incubated for one hour in PE anti-human CD71 Antibody in the dark at 4°C (1:100; Biolegend). Cells were washed twice with PBS and then and then analysed using a flow cytometer (FACsFortessa ...
-
bioRxiv - Developmental Biology 2019Quote: ... or CD44-PerCP (BioLegend, IM-7, 1:150), at 4°C for 30□min ...
-
bioRxiv - Genomics 2023Quote: ... CD169/Siglec-1 (Clone 7-239, Biolegend 346002), or CD209/DC-SIGN (Clone 120507 ...
-
bioRxiv - Cell Biology 2023Quote: ... Viability dye 7-AAD (1:250; BioLegend, 420403) was added for 10 min at RT ...
-
bioRxiv - Cell Biology 2023Quote: ... Pecy-7 (Biolegend, clone HCD14, diluted 1/100); anti-CD16 ...
-
bioRxiv - Microbiology 2023Quote: ... and 7 AAD (#420404; Biolegend 1:25 dilution) diluted in Annexin V binding buffer ...
-
bioRxiv - Immunology 2023Quote: ... 7-aminoactinomycin-D (7-AAD; BioLegend), FAS-PEcy7 (DX2 ...
-
bioRxiv - Developmental Biology 2023Quote: ... 7-aminoactinomycin D (7-AAD) (Biolegend) was used as death cell marker and added 15’ before the analysis ...
-
bioRxiv - Genomics 2019Quote: ... Stained cells were washed thrice with Flow buffer and 7-AAD viability dye (3-5µl, BioLegend) was added before quantification ...
-
bioRxiv - Immunology 2022Quote: ... anti-CD138 (APC-Cy-7, clone 4B4-1 – BioLegend) and anti-CD134 (BV650 ...
-
bioRxiv - Microbiology 2023Quote: ... CD44-PE/Cyanine 7 (1:100, clone: IM7, BioLegend), CD69-FITC (1:100 ...
-
bioRxiv - Developmental Biology 2023Quote: ... or 7-AAD viability dye (BioLegend; 1 µl/sample). The following antibodies were used per 100 µl of staining volume for 1×106 cells ...
-
bioRxiv - Immunology 2024Quote: ... anti-CD137 (APC-Cy-7, clone 4B4-1 – BioLegend) and anti-CD134 (BV650 ...
-
bioRxiv - Microbiology 2021Quote: ... Sections were blocked with 10% sheep serum and 1% BSA in TBS for 30 min then incubated at 4°C overnight with 1 μg ml−1 rabbit polyclonal anti-tubulin β-3 IgG (Biolegend) and 1% BSA in TBS ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.3% PBST for 3 days at 4°C on rotating incubator (NFH, 1:500, Abcam, ab4680; Tubulin β-III, 1:200, Biolegend, 801201). Whole muscles were washed in 0.3% PBST for 5 hours then incubated in secondary antibodies for 48h at 4°C on rotating incubator (AlexaFluor 568 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 1) AnnexinV/7-AAD staining (Kit from Biolegend Cat# 640922): At the end of the EMT experiment described above ...
-
bioRxiv - Immunology 2023Quote: ... anti-CD38 BV510 (1:50 dilution, clone HB-7, BioLegend), anti-CD20 PE-Cy7 (1:50 dilution ...
-
bioRxiv - Immunology 2023Quote: ... anti-CD38 BV421 (1:100 dilution, clone HB-7, BioLegend), anti-CD20 BV510 (1:50 dilution ...
-
bioRxiv - Immunology 2024Quote: ... cells were incubated with 7-AAD (Biolegend #420404, 1:20). Total B cells were identified as DAPI−CD3−B220+ and sorted using a BD FACS Melody ...
-
bioRxiv - Immunology 2021Quote: ... Bcl-6 FITC (Biolegend 358513, 1:100), and Glut-1 AlexaFluor 647 (Abcam ab115730 ...
-
bioRxiv - Immunology 2023Quote: ... Single cell suspensions were then tagged with mouse Total-Seq anti-mouse hashtags C0306 (Brafi: Hashtag 6) and C0307 (Brafi + C-Me: Hashtag 7) (BioLegend) according to manufacturers’ protocols.